Effects of resveratrol on ovarian morphology, plasma anti-mullerian hormone, IGF-1 levels, and oxidative stress parameters in a rat model of polycystic ovary syndrome
dc.contributor.author | Ergenoglu M. | |
dc.contributor.author | Yildirim N. | |
dc.contributor.author | Yildirim A.G.S. | |
dc.contributor.author | Yeniel O. | |
dc.contributor.author | Erbas O. | |
dc.contributor.author | Yavasoglu A. | |
dc.contributor.author | Taskiran D. | |
dc.contributor.author | Karadadas N. | |
dc.date.accessioned | 2019-10-26T21:21:59Z | |
dc.date.available | 2019-10-26T21:21:59Z | |
dc.date.issued | 2015 | |
dc.department | Ege Üniversitesi | en_US |
dc.description.abstract | Objective: To evaluate the effects of resveratrol in a rat model of polycystic ovarian syndrome (PCOS). Study Design: After PCOS model was formed by subcutaneous dihydrotestosterone pellets, rats were randomly divided into 2 groups. The first group (n = 7) was treated with 1 mL/kg/d isotonic saline and the second group (n = 7) was treated with 10 mg/kg/d resveratrol. Seven rats were taken as controls without any medication. Results: Our results showed (1) significant reduction in the number of antral follicle counts (P < .01); (2) significantly decreased plasma anti-Mullerian hormone and insulin-like growth factor 1 levels (P < .01 and P < .05, respectively); (3) significantly lower superoxide dismutase activity (P < .05); and (4) significantly increased glutathione peroxidase content (P < .01) following resveratrol treatment. Conclusion: Resveratrol appears to be effective in the treatment of PCOS due to its antioxidant properties. Future clinical studies with different dosages might provide useful implementations to our practice. © The Author(s) 2015. | en_US |
dc.identifier.doi | 10.1177/1933719115570900 | en_US |
dc.identifier.endpage | 947 | en_US |
dc.identifier.issn | 1933-7191 | |
dc.identifier.issue | 8 | en_US |
dc.identifier.pmid | 25667201 | en_US |
dc.identifier.scopusquality | Q2 | en_US |
dc.identifier.startpage | 942 | en_US |
dc.identifier.uri | https://doi.org/10.1177/1933719115570900 | |
dc.identifier.uri | https://hdl.handle.net/11454/16927 | |
dc.identifier.volume | 22 | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | SAGE Publications Inc. | en_US |
dc.relation.ispartof | Reproductive Sciences | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | anti-Mullerian hormone | en_US |
dc.subject | oxidative stress | en_US |
dc.subject | polycystic ovary syndrome | en_US |
dc.subject | rat model | en_US |
dc.subject | resveratrol | en_US |
dc.title | Effects of resveratrol on ovarian morphology, plasma anti-mullerian hormone, IGF-1 levels, and oxidative stress parameters in a rat model of polycystic ovary syndrome | en_US |
dc.type | Article | en_US |